Benefits, Risks of SGLT2 Inhibitors Explored at Session
ADA 74th Scientific Sessions
Sessions Highlight Strides in
Results Presented on Motivating Patients With Diabetes
Diabetes Navigator Program Reduces A1C Levels for Patients in Alabama
Afrezza, Inhaled Insulin, Wins FDA Approval
Can Early Use of Insulin, GLP-1 Halt Diabetes Progression?
Integrated Treatment for Diabetes, Depression Gains Notice, With Help from ACA
Value-Engineered Translation: Developing Biotherapeutics That Align With Health-System Needs
Commentary
A Novel Pharmaceutical-ACO Collaboration: the Merck/Heritage Provider Network Open Innovation Challenge
Accountable care is forcing providers to develop new capacities and strategies for managing cost and quality trends. Prospectively managing the health of populations requires shifting the focus of care delivery from episodic interventions to continuous population management. As a result, accountable care organizations (ACOs) are dedicating considerable focus to developing the infrastructure and tools needed to help patients manage their chronic conditions. This is a significant departure from traditional care-delivery models and will require provider organizations to develop new partnerships and embrace new methods.
Pharma-Payer Partnerships Seek to Prove Effectiveness of Care
Can Gastric Bypass Surgery Be a Cure for Diabetes Mellitus?
Early Cellular Aging: Salt and the Telomeres
AJMC Peer Exchange: Nationwide, Patient-Centered Strategy Needed to Battle Obesity, T2DM
Peer Exchange: Recorded during Patient-Centered Diabetes Care, Princeton, N.J., April 10, 2014.
Aging and Cognitive Decline in Diabetes
Environmental Pollutants: A Risk Factor for Obesity and Diabetes
Challenge Winner Sees Promise in Daily App Check
